APA (7th ed.) Citation

K, D., GD, B., LJ, G., AA, O., JR, L., T, R., . . . S, S. (2022). Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series. Oncotarget, 13, 1174. https://doi.org/10.18632/oncotarget.28294

Chicago Style (17th ed.) Citation

K, Drenner, et al. "Addendum: The Value of Comprehensive Genomic Sequencing to Maximize the Identification of Clinically Actionable Alterations in Advanced Cancer Patients: A Case Series." Oncotarget 13 (2022): 1174. https://doi.org/10.18632/oncotarget.28294.

MLA (9th ed.) Citation

K, Drenner, et al. "Addendum: The Value of Comprehensive Genomic Sequencing to Maximize the Identification of Clinically Actionable Alterations in Advanced Cancer Patients: A Case Series." Oncotarget, vol. 13, 2022, p. 1174, https://doi.org/10.18632/oncotarget.28294.